Compared to placebo (dummy medicine), tolvaptan (a class of medicine known as vasopressin 2 receptor antagonists) probably preserves kidney function and slows the increase in total kidney volume; ...
An expert provides answers to readers’ questions regarding different aspects of the kidney cancer experience, such as protein intake and clinical trials. From treatment decisions to protein intake, ...
A New Drug Candidate Can Shrink Kidney Cysts Jan. 22, 2024 — A compound originally developed as a cancer treatment may hold promise for treating polycystic kidney disease (ADPKD), which affects ...
A recent study conducted by UCLA Health Jonsson Comprehensive Cancer Center researchers found that new, non-invasive imaging technology can detect clear-cell renal cell carcinoma, the most common ...
Kidney failure, also called end-stage renal disease (ESRD), is a condition where your kidneys are functioning at 15% of their normal levels. Kidneys help filter out waste products and excessive ...
A study by researchers at UCLA has discovered a new, non-invasive scanning technology that can detect the most common type of kidney cancer, clear-cell renal cell carcinoma (CCRCC), an ANI report ...
Oct. 7, 2024 — Doctors have long believed the cancer drug 5-fluorouracil works by damaging the building blocks of DNA, but researchers have now found that in certain cancers, it kills cells by ...